Pakistan Issues a Preliminary Determination in the Antidumping Duty Investigation into Ibuprofen from the United States and China
Pakistan Issues a Preliminary Determination in the Antidumping Duty Investigation into Ibuprofen from the United States and China
On October 15, 2026, Pakistan’s National Tariff Commission (NTC) issued a preliminary determination in the antidumping (AD) investigation into ibuprofen from the United States and China. The provisional duties assigned to U.S. producers/exporters can be found on page 2 of the preliminary determination notice.
| KEY DATES | |
|---|---|
| Hearing Request Deadline | November 15, 2026 |
| Final Determination* | April 13, 2027 |
*Estimated
Products Under Investigation
The product subject to this investigation is ibuprofen, used primarily for the relief of symptoms associated with arthritis, fever, and as an analgesic for pain. Ibuprofen is classified under tariff code 2916.39.10.
Contact Us
The U.S. Department of Commerce’s Office of Trade Remedy Compliance supports U.S. companies facing foreign trade remedy proceedings (antidumping duty, countervailing duty, and safeguard actions) and ensures foreign governments comply with their international trade obligations. Should you have any questions, please contact TRCS@trade.gov. For more information, visit Office of Trade Remedy Compliance.